Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack.
The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering a CAGR of 6.8% during the study period. The growth in geriatric population coupled with increase in incidence of peripheral artery disease are the major factors that drive the growth of the peripheral artery disease market. In addition, introduction of advanced interventional products such as drug coated balloons also boost the market growth. However, restenosis (reoccurrence of the disease post treatment) majorly restraints the market growth.
The global peripheral artery disease market is segmented on the basis of type and region. Based on type, the market is divided into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
This report provides an extensive analysis of the current and emerging market trends and dynamics in the market through 2016–2023 that helps identify the upcoming market opportunities.
Recent industry trends and developments and the future opportunities are also covered.
Extensive knowledge about the key market players and their strategies is provided.
Comprehensive analysis of the various factors that drive and restrain the growth of the market is provided.
KEY MARKET SEGMENTS
Peripheral Angioplasty Balloons
Cutting and Scoring Balloons
Inferior Vena Cava (IVC) Filters
Plaque Modification Devices
Mechanical Thrombectomy Devices
Aspiration Thrombectomy Devices
Rheolytic Thrombectomy Devices
Hemodynamic Flow Alteration Devices
Embolic Protection Devices
Chronic Total Occlusion Devices
Vascular Closure Devices
Balloon Inflation Devices
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
Key market players
The key players operating in this market include
Boston Scientific Corporation
Cardinal Health, Inc.
C. R. Bard, Inc.
The Spectranetics Corporation
B. Braun Melsungen AG